C12N - Micro-organisms or enzymes; Compositions thereof; Propagating, preserving, or maintaining micro-organisms; Mutation or genetic engineering; Culture media

More topics under "C12N - Micro-organisms or enzymes; Compositions thereof; Propagating, preserving, or maintaining micro-organisms; Mutation or genetic engineering; Culture media" (918,689)
C12N 1 - Micro-organisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving micro-organisms or compositions thereof; Processes of preparing or isolating a composition containing a micro-organism; Culture media therefor (148,866)
C12N 11 - Carrier-bound or immobilised enzymes; Carrier-bound or immobilised microbial cells; Preparation thereof (12,439)
C12N 13 - Treatment of micro-organisms or enzymes with electrical or wave energy, e.g. magnetism, sonic waves (3,958)
C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210)
C12N 3 - Spore-forming or isolating processes (415)
C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629)
C12N 7 - Viruses, e.g. bacteriophages; Compositions thereof; Preparation or purification thereof (26,637)
C12N 9 - Enzymes, e.g. ligases (6.); Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating, or purifying enzymes (141,535)

Patents for C12N - Micro-organisms or enzymes; Compositions thereof; Propagating, preserving, or maintaining micro-organisms; Mutation or genetic engineering; Culture media (9,992)
01/2012
01/25/2012	EP2410331A1 Aminoacyl-tRNA synthetase for aminoacylation tRNA with unnatural amino acids
01/25/2012	EP2409981A1 Glucanases, nucleic acids encoding them and methods for making and using them
01/25/2012	EP1613735B1 Expanding the eukaryotic genetic code
01/19/2012	US20120015810 Tubulin regulatory elements for use in plants
01/19/2012	US20120015042 Rna sequence-specific mediators of rna interference
01/17/2012	US8097277 Charge-dynamic polymers and delivery of anionic compounds
01/17/2012	US8097252 Methods and compositions for administering therapeutic and diagnostic agents
01/12/2012	US20120009635 Metabolically Engineered Bacterial Strains Having Non-Functional Endogenous Gluconate Transporters
01/12/2012	US20120009559 Automated cell culture system and process
01/11/2012	EP2404931A1 Glucanases, nucleic acids encoding them and methods for making and using them
01/11/2012	EP2404930A1 Glucanases, nucleic acids encoding them and methods for making and using them
01/11/2012	EP2404929A1 Glucanases, nucleic acids encoding them and methods for making and using them
01/11/2012	EP2404928A1 Glucanases, nucleic acids encoding them and methods for making and using them
01/11/2012	EP2404676A1 Microfluidic Control Structures
01/11/2012	EP1649025B1 Methods of decoupling reaction scale and protein synthesis yield in batch mode
01/11/2012	EP1629088B1 Prostate stem cell antigen (psca) variants and subsequences thereof
01/11/2012	EP1601784B1 Multiple controls for molecular genetic analyses
01/10/2012	US8092531 Human skin equivalents expressing exogenous polypeptides
01/10/2012	CA2419541C Interleukin-22 polypeptides, nucleic acids encoding the same and methods for the treatment of pancreatic disorders
01/05/2012	US20120004183 Unnatural reactive amino acid genetic code additions
01/05/2012	US20120003756 Chromatographic assay system
01/04/2012	EP2402448A2 Production of polyunsaturated fatty acids in oleaginous yeasts
01/03/2012	US8088912 A polyvalent multimeric complex formed from a plurality of circularly permuted chimeric pRNA molecules, each carrying a stabilized biologically active moiety; degradation resistant stabilized ribozyme is correctly folded such that it remains intracellularly active
01/03/2012	US8088911 Tubulin regulatory elements for use in plants
12/2011
12/29/2011	US20110318811 Compositions and methods of using a synthetic dnase i
12/28/2011	EP2399588A1 Nucleoside derivatives as inhibitors of RNA-dependent RNA viral polymerase
12/27/2011	US8084598 Bioionformality detectable group of novel regulatory oligonucleotides and uses thereof
12/27/2011	US8084028 Antibodies to VLA-1
12/22/2011	US20110312532 Gene Expression Markers for Breast Cancer Prognosis
12/22/2011	US20110311540 Wisp polypeptides and nucleic acids encoding same
12/22/2011	US20110311530 Truncated baff receptors
12/21/2011	EP2397549A2 Non-stochastic generation of genetic vaccines and enzymes
12/21/2011	EP1692161B1 Chimeric chemokine receptor polypeptides
12/21/2011	CN102288532A 具有高纯度x－染色体和y－染色体的精子群 Chromosome with high purity x- and y- chromosome sperm group
12/20/2011	US8080642 Severe acute respiratory syndrome DNA compositions and methods of use
12/20/2011	CA2202028C Tie-2 ligands, methods of making and uses thereof
12/15/2011	US20110306651 Rna interference mediating small rna molecules
12/15/2011	US20110305721 Compounds and methods for immunotherapy and diagnosis of tuberculosis
12/13/2011	US8076059 Adjuvant capable of specifically activating the adaptive immune response
12/13/2011	US8075888 Methods of treatment using antibodies to IL-17 homologous polypeptides
12/08/2011	US20110300600 Methods and compositions for delivering polynucleotides
12/08/2011	US20110300537 Methods of detecting sequence differences
12/08/2011	US20110300145 Interferon Alpha Antibodies And Their Uses
12/07/2011	EP2393028A2 Methods for selecting medications
12/07/2011	EP2392923A1 Method of prodcucing proteins comprising unnatural amino acid
12/07/2011	EP2392665A2 Production of polyunsaturated fatty acids in oleaginous yeasts
12/07/2011	EP2392664A2 Production of polyunsaturated fatty acids in oleaginous yeasts
12/07/2011	EP2392582A2 Lactobacillus acidophilus nucleic acid sequences encoding cell surface protein homologues and uses therefore
12/07/2011	EP2392581A2 Lactobacillus acidophilus nucleic acid sequences encoding cell surface protein homologues and uses therefore
12/07/2011	EP1667521B1 Methods for treatment of insulin-like growth factor-1 (igf-1) deficiency
12/07/2011	EP1594476B1 Method and apparatus for treating bodily tissues with medicinal substance
12/06/2011	US8071838 Targeted and regional cellular ablation in zebrafish
12/06/2011	US8071645 Antiinflammatory or antiproliferation agents, wound healing agents for wounds and metabolic agents
12/06/2011	US8071313 Primers and primer sets for use in methods to detect the presence of Acidovorax avenae subsp. citrulli
12/06/2011	US8071107 Nucleic acids encoding modified human immunodeficiency virus type 1 (HIV-1) group M consensus envelope glycoproteins
12/01/2011	US20110294165 Variant humicola grisea cbh1.1
12/01/2011	US20110294164 Variant humicola grisea cbh1.1
11/2011
11/30/2011	EP2389953A1 Method of inhibiting receptor tyrosine kinases with an extracellular antagonist and an intracellular antagonist
11/29/2011	US8067608 Hedgehog pathway antagonists
11/29/2011	US8067389 Silencing of TGFβ type II receptor expression by siRNA
11/29/2011	US8067239 Reagents for recombinogenic engineering and use thereof
11/29/2011	US8067222 Pectate lyases, nucleic acids encoding them and methods for making and using them
11/29/2011	US8067167 Hybrid antibodies
11/29/2011	CA2522535C Chemokine receptor binding heterocyclic compounds with enhanced efficacy
11/29/2011	CA2448208C Influenza vaccine composition
11/24/2011	US20110289611 Rna sequence-specific mediators of rna interference
11/24/2011	US20110287543 Cell culture methods and devices utilizing gas permeable materials
11/24/2011	US20110287542 Cell culture methods and devices utilizing gas permeable materials
11/24/2011	US20110287511 Novel Trichoderma Genes
11/24/2011	US20110287506 Genetically modified yeast species, and fermentation processes using genetically modified yeast
11/24/2011	US20110287505 Genetically modified yeast species, and fermentation processes using genetically modified yeast
11/23/2011	EP1644734B1 Method for assaying protein-protein interaction
11/23/2011	EP1578952B1 Direct snp detection with unamplified dna
11/23/2011	EP1476561B1 Amplifying repetitive nucleic acid sequences
11/22/2011	US8063263 Methods for the treatment or prevention of scars and/or keloids
11/22/2011	US8062849 Quantitative multiplex methylation-specific PCR
11/22/2011	CA2486007C Delivery of nucleic acid-like compounds
11/17/2011	US20110281931 Rna sequence-specific mediators of rna interference
11/16/2011	EP2386653A2 Methods for the utilization of novel target genes related to immune-mediated diseases
11/16/2011	CN1863921B Methods for expression and purification of immunotoxins
11/16/2011	CN1703521B Quantification of gene expression
11/16/2011	CN102240397A Production of high mannose proteins in plant culture
11/15/2011	USRE42931 Covalent tethering of functional groups to proteins
11/15/2011	US8058398 Modified G-CSF polypeptide
11/15/2011	US8058004 Microarray synthesis and assembly of gene-length polynucleotides
11/15/2011	US8057993 Methods for identification of coronaviruses
11/15/2011	CA2518295C Methods of inducing the expression of bone morphogenetic proteins (bmps) and transforming growth factor-.beta. proteins (tgf-.beta.s) in cells
11/15/2011	CA2252970C Optimization of cells for endogenous gene activation
11/10/2011	US20110275156 Delivery of DNA or RNA Via Gap Junctions from Host Cells to Target Cells and a Cell-Based Delivery System for Antisense or siRNA
11/09/2011	EP2385104A1 Variant Scytalidium thermophilium CBH1
11/09/2011	EP2385103A2 Variant Hypocrea jecorina CBH1
11/09/2011	EP1592796B1 Helminth-derived antigens having capacity of providing protection against parasites
11/09/2011	CN102234334A Immunoglobulin chimeric monomer - dimer heterozygote
11/08/2011	US8053410 Pegylated factor VII glycoforms
11/08/2011	CA2408939C High purity x-chromosome bearing and y-chromosome bearing populations of spermatozoa
11/03/2011	US20110269974 Polymer Derivatives
11/03/2011	US20110269120 Methods and compositions for detecting promoter activity and expressing fusionproteins
11/02/2011	EP1696790B1 Methods for assessing metabolic substrate utilization and effectiveness of a therapy
11/01/2011	US8048985 Vascular Leak Syndrome; polypeptide toxophore from a DT; has cytotoxicity comparable to that of a DT molecule
11/01/2011	US8048631 Reducing non-target nucleic acid dependent amplifications: amplifying repetitive nucleic acid sequences

1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 ... 100